from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0577/TB27.3

LFCtreatmentdescriptionclass of inhibitor

-0.108

Amikacinug/mL Amikacintranslation

-0.892

Cap5-10ug/mL Capreomycintranslation

-0.531

Rox10-50 ug/mL Roxithromycintranslation

0.121

SM2-5 ug/mL Streptomycintranslation

-0.690

Tet5-10 ug/mL Tetracyclinetranslation

-0.163

Rif0.2-5ug/mL Rifampicintranscription

0.244

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.174

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

3.178

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.088

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.018

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.165

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.152

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.061

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.433

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.569

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.016

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.958

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.149

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.751

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.023

KCN5-20 ug/mL Potassium cyaniderespiration

0.090

NaN30.2-2 mM Sodium aziderespiration

-1.031

Nigericin50 uM Nigericinrespiration

0.421

TRC10-150 ug/mL Triclosanrespiration

-0.813

TRZ10-25 ug/mL Thioridazinerespiration

2.453

Valinomycin0.5-10 uM Valinomycinrespiration

-1.075

ZnSO42 mM ZnSO4respiration

-0.508

menadione6-10 ug/mL Menadionerespiration

-0.035

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.058

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.415

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.109

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.389

NRP_1Non-replicating persistence stage 1dosRassociated

-0.112

Amp0.2mg/mL AmpicillincellWall

0.290

Cephalexin20-100 ug/mL CephalexincellWall

-0.355

Cerulenin0.32-5 ug/mL CerulenincellWall

0.484

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.003

EMB10-20 ug/mL EthambutolcellWall

-0.234

Eta12-40 ug/mL EthionamidecellWall

-0.057

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.171

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.113

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.267

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.598

BZA0.12 mg/mL BenzamidearomaticAmides

-0.498

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.234

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.176

H2O24 mM hydrogen peroxideDNAdamaging

0.157

Levo10 ug/mL LevofloxacinDNAdamaging

-0.229

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.219

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.025

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.133

UVUV-irradiationDNAdamaging

1.195

ARP41-4 ug/mL Antitubercular compound ARP4?

0.023

Antimycin12.5-50 ug/mL Antimycin A?

-0.029

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.124

PA_110-50 ug/mL Antitubercular compound PA-1?

0.371

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.138

PA8240.2-2 ug/mL PA-824?

-0.534

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.150

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.224

Verapamil50 uM Verapamil?

0.454

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.085

methoxatin10-20 ug/mL Methoxatin?